Xia Feng, Zhang Qiao, Ndhlovu Elijah, Zheng Jun, Gao Hengyi, Xia Guobing
Department of Hepatic Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei.
Department of Emergency Medicine, Zhongshan People's Hospital Affiliated to Guangdong Medical University.
Eur J Gastroenterol Hepatol. 2023 May 1;35(5):591-599. doi: 10.1097/MEG.0000000000002535. Epub 2023 Mar 13.
Microvascular invasion (MVI) is defined as the presence of micrometastatic cancer cell emboli in hepatic vessels, including small vessels, and at present, researchers believe that is an important factor for early postoperative recurrence and survival. Here, we developed and validated a preoperative predictive model for the presence of MVI in patients with ruptured hepatocellular carcinoma (rHCC).
We retrospectively collected data for 210 rHCC patients who underwent staged hepatectomy at Wuhan Tongji Hospital, and 91 patients who underwent staged hepatectomy at Zhongshan People's Hospital between January 2010 and March 2021. Then, the former was used as the training cohort and the latter was used as the validation cohort. Logistic regression was used to screen for variables associated with MVI, and these variables were used to construct nomograms. We used R software to assess the discrimination, calibration ability, as well as clinical efficacy of nomograms.
Multivariate logistic regression analysis identified four risk factors independently associated with MVI: max tumor length [odds ratio (OR) = 1.385; 95% confidence interval (CI), 1.072-1.790], number of tumors (OR = 2.182; 95% CI, 1.129-5.546), direct bilirubin (OR = 1.515; 95% CI, 1.189-1.930), and alpha-fetoprotein (cutoff = 400 ng/mL) (OR = 2.689; 95% CI, 3.395-13.547). Nomograms were built from the four variables and they were tested for discrimination and calibration, and the results were good.
We developed and validated a preoperative predictive model for the presence of MVI in patients with ruptured HCC. This model can help clinicians identify patients at risk of MVI and make better treatment options.
微血管侵犯(MVI)被定义为在肝血管(包括小血管)中存在微转移癌细胞栓子,目前,研究人员认为这是术后早期复发和生存的重要因素。在此,我们开发并验证了一种用于预测破裂性肝细胞癌(rHCC)患者MVI存在情况的术前预测模型。
我们回顾性收集了2010年1月至2021年3月期间在武汉同济医院接受分期肝切除术的210例rHCC患者以及在中山市人民医院接受分期肝切除术的91例患者的数据。然后,将前者作为训练队列,后者作为验证队列。采用逻辑回归筛选与MVI相关的变量,并将这些变量用于构建列线图。我们使用R软件评估列线图的区分度、校准能力以及临床疗效。
多因素逻辑回归分析确定了与MVI独立相关的四个危险因素:肿瘤最大径[比值比(OR)=1.385;95%置信区间(CI),1.072 - 1.790]、肿瘤数量(OR = 2.182;95% CI,1.129 - 5.546)、直接胆红素(OR = 1.515;95% CI,1.189 - 1.930)以及甲胎蛋白(临界值 = 400 ng/mL)(OR = 2.689;95% CI,3.395 - 13.547)。由这四个变量构建的列线图经检验其区分度和校准效果良好。
我们开发并验证了一种用于预测破裂性肝细胞癌患者MVI存在情况的术前预测模型。该模型可帮助临床医生识别有MVI风险的患者并做出更好的治疗选择。